# FOLFIRI Versus Irinotecan as Second-line Treatment in Metastatic Colorectal Cancer Patients

> **NCT02935764** · PHASE3 · UNKNOWN · sponsor: **Fudan University** · enrollment: 164 (estimated)

## Conditions studied

- Colorectal Carcinoma

## Interventions

- **DRUG:** Irinotecan
- **DRUG:** 5-fluorouracil
- **DRUG:** Leucovorin

## Key facts

- **NCT ID:** NCT02935764
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-10
- **Primary completion:** 2019-10
- **Final completion:** —
- **Target enrollment:** 164 (ESTIMATED)
- **Last updated:** 2016-10-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02935764

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02935764, "FOLFIRI Versus Irinotecan as Second-line Treatment in Metastatic Colorectal Cancer Patients". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02935764. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*